Skip to Main Content
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact

News

Mar 28, 2022Blog | Member News, Healthcare

State-of-the-art facility will headquarter research efforts in Boston and New York to accelerate the development of RNA and DNA-based medicines

This week, New England Council member Lilly announced the launch of its Lilly Institute for Genetic Medicine. Lilly intends for the Institute to enhance the company’s development of genetic medicines in a way that is “fundamentally different” than what is available today, according to Andrew C. Adams, Vice President of Genetic Medicine at Lilly and Co-Director of the Institute.

In addition to the launch, Lilly has announced an investment of approximately $700 million intended for the company to establish a state-of-the-art facility at a new site in the Boston Seaport. With this investment, Lilly plans to advance RNA-based therapeutics and build on its acquisition and expansion of Prevail Therapeutics, a gene therapy pioneer based in New York City. Together, these companies hope to develop therapies that have the potential to “treat or prevent diseases in a manner that is challenging or not possible with traditional medicines,” according to a press release by Lilly.

When speaking on the company’s goals for the Institute, Vice President Adams stated that he anticipates the launch will allow Lilly to “pair cutting-edge technologies” with “its deep biological expertise in several areas,” and develop medicines that “target the root cause of diseases.”

The New England Council congratulates Lilly on its launch of the Lily Institute for Genetic Medicine and looks forward to how the Institute will transform the development of genetic medicines.

Read more about the launch here.

Council Related News
Read Article Blog | Member News, Energy & Environment

Dominion Energy Charitable Foundation awards grants to 352 Nonprofits

Read Article Blog | Member News, Higher Education

University of New England announces partnership with Atlantic Hospitality to advance student careers

Read Article Blog | Member News, Higher Education

A study released by the CCIC reveals independent colleges are vital to the state’s economy

Read Article Blog | Member News, Energy & Environment

Unitil and Eversource Announce Water Utility Deals

Read Article Blog | Member News, Technology & Innovation

General Dynamics Electric Boat awarded $12.2 billion contract to boost shipbuilder pay and build two new submarines

View Related News

©2025 New England Council
All rights reserved.

Privacy Policy Website Design by Jackrabbit

Boston Office

98 North Washington Street
Suite 303
Boston, MA 02114

(617) 723-4009

necouncil@newenglandcouncil.com

Washington Office

1411 K Street, NW
Suite 700
Washington, D.C. 20005

(202) 547-0048

necouncil@newenglandcouncil.com

Website Design by Jackrabbit